Update on Genetic Testing for Prostate Cancer: Challenges and Opportunities with Dr. Kathleen Cooney, MD, MACP

  • The presentation will focus on summarizing our understanding of the contribution of heritable factors to prostate cancer predisposition and the difficulties researchers have faced in identifying susceptibility genes impacting this common cancer. There have been statements from NCCN and other societies recommending genetic testing for unaffected men presumed to be at high risk for the disease as well as for men with metastatic prostate cancer. Because prostate cancer is such a common disease, this has created significant challenges for providers and patients.

    Level of Instruction: Intermediate

George Barth Geller Distinguished Professor of Medicine and Chair of the Department of Medicine, Duke University School of Medicine, in Durham, North Carolina

Dr. Cooney was recruited to Duke University in 2018 to become the tenth chair of the Department of Medicine. As chair of the Duke Department of Medicine, Dr. Cooney oversees the largest department in the School of Medicine. She continues to teach and mentor many clinical and laboratory trainees as well as faculty. Dr. Cooney is a medical oncologist focused on caring for men with prostate cancer and internationally known for investigations examining the genetic epidemiology of prostate cancer. She discovered a recurrent mutation in the HOXB13 gene that increases the chances of being diagnosed with prostate cancer. Her current research focuses on identifying germline mutations associated with lethal and aggressive prostate cancer as well as prostate cancer in African American men. Dr. Cooney received her MD from the University of Pennsylvania Perelman School of Medicine in Philadelphia and completed her training in Internal Medicine and Hematology/Oncology at the University of Michigan. She previously served as chair of Internal Medicine at the University of Utah; before that, she served for nearly 10 years as the division chief of Hematology/Oncology and deputy director of the Comprehensive Cancer Center at the University of Michigan.

Genomic Science Liaison, Ambry Genetics

Jessica Laprise joined Ambry in 2020 as the Oncology Genomic Science Liaison for the New England Region. In her current role she serves as a clinical liaison for the field team to educate health care providers and key opinion leaders on genetic testing and genomic medicine. Jessica previously worked as a clinical cancer genetic counselor at The Cancer Genetics and Prevention Program at Women and Infants Hospital/Warren Alpert School of Medicine, Brown University in Providence, Rhode Island for over 15 years. She has been actively involved with clinical research with multiple national presentations and numerous peer-reviewed publications. Jessica has worked closely with the National Society of Breast Centers (NCoBC) serving as the Co-chair for their annual genetics pre-conference for multiple years and contributed to the development of the organization’s Cancer Genetics and Risk Certification Program. She is a member of the National Society of Genetic Counselors Access and Service Delivery Committee and is particularly passionate about increasing patient access to genetics services and provider education.

Register Now
  • Thu, August 25, 2022
  • 11:00am PDT
  • Duration: 1 hour
  • C.E.U.
    1 Category 1 Contact Hour
  • P.A.C.E. 1 unit

Upcoming Webinars

Subscribe to receive notifications for future webinars.

Search Results

Start your search...